1177.HK - Sino Biopharmaceutical Limited

HKSE - HKSE Delayed Price. Currency in HKD
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
27,701,313
28,780,412
26,861,356
23,647,224
24,234,030
Cost of revenue
5,538,573
5,795,510
5,332,095
5,182,320
4,926,268
Gross profit
22,162,740
22,984,902
21,529,261
18,464,904
19,307,762
Operating expenses
Research development
-
-
-
2,626,709
2,398,712
Selling general and administrative
12,845,682
12,564,007
12,703,627
11,628,561
11,908,760
Total operating expenses
17,659,244
16,948,603
17,185,822
14,160,755
14,216,510
Operating income or loss
4,503,496
6,036,299
4,343,439
4,304,149
5,091,252
Interest expense
330,665
439,058
308,617
323,368
229,950
Income before tax
11,348,770
5,778,604
18,572,673
5,013,044
5,583,822
Income tax expense
1,192,360
775,986
1,957,880
672,377
889,448
Income from continuing operations
10,156,410
5,002,618
16,614,793
4,340,667
4,694,374
Net income
8,049,109
2,543,570
14,608,412
2,771,086
2,706,794
Net income available to common shareholders
8,049,109
2,543,570
14,608,412
2,771,086
2,706,794
Basic EPS
-
0.14
0.78
0.15
0.15
Diluted EPS
-
0.12
0.73
0.15
0.15
Basic average shares
-
18,622,249
18,768,650
18,800,284
18,811,056
Diluted average shares
-
19,017,202
19,282,955
18,800,284
18,811,056
EBITDA
-
7,264,646
19,873,846
6,991,248
7,279,800